CircPOSTN acted as an oncogene to expedite glioma tumorigenesis via targeting miR-185-5p/KIF1B axis, indicating a potential therapeutic target for glioma.
CircPOSTN competes with KIF1B for miR-185-5p binding sites to promote the tumorigenesis of glioma.